Business/Politics Vir Biotech CEO says its Covid antibody therapy ‘stands up nicely’ to all variants A monoclonal antibody Covid therapy from Vir Biotechnology and GlaxoSmithKline “stands up nicely” to all variants of the virus, Vir President and